The selloff came as more than $2.7 trillion worth of options expired, an event which typically spurs heightened volatility.
The investigation is the latest worry for UnitedHealth, which is already facing an antitrust probe and regulatory pushback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback